Janux Therapeutics, Inc. reports

Location
10955 Vista Sorrento Parkway, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/6/2024, 04:25 PM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 6, 2024 Sep 30, 2024
8-K Report | Data 8-K Nov 6, 2024 Nov 6, 2024
SC 13G/A Report SC 13G/A Nov 4, 2024
SC 13D/A Report SC 13D/A Oct 25, 2024
SC 13G Report SC 13G Oct 23, 2024
SC 13D/A Report SC 13D/A Oct 22, 2024
SC 13D/A Report SC 13D/A Oct 22, 2024
SC 13D/A Report SC 13D/A Sep 16, 2024
SC 13D/A Report SC 13D/A Sep 16, 2024
SC 13D/A Report AMENDMENT NO. 2 Aug 9, 2024
10-Q Report | Data 10-Q Aug 7, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 7, 2024 Aug 7, 2024
8-K Report | Data 8-K Jul 22, 2024 Jul 19, 2024
8-K Report | Data 8-K Jun 28, 2024 Jun 26, 2024
SC 13D/A Report SC 13D/A Jun 5, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
8-K Report | Data 8-K May 8, 2024 May 7, 2024
10-K Report | Data 10-K Mar 8, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 8, 2024 Mar 8, 2024
SC 13D/A Report SC 13D/A Mar 6, 2024
SC 13D/A Report SC 13D/A Mar 4, 2024
8-K Report | Data 8-K Feb 29, 2024 Feb 28, 2024
8-K Report | Data 8-K Feb 28, 2024 Feb 28, 2024
8-K Report | Data 8-K Feb 27, 2024 Feb 27, 2024
8-K Report | Data 8-K Feb 26, 2024 Feb 26, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report Feb 9, 2024
SC 13G/A Report SC 13G/A Feb 1, 2024
SC 13D/A Report SC 13D/A Nov 16, 2023
10-Q Report | Data 10-Q Nov 7, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 7, 2023 Nov 7, 2023
10-Q Report | Data 10-Q Aug 8, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 8, 2023 Aug 8, 2023
8-K Report | Data 8-K Jul 18, 2023 Jul 17, 2023
8-K Report | Data 8-K Jul 17, 2023 Jul 17, 2023
SC 13G Report SC 13G Jul 10, 2023
8-K Report | Data 8-K Jun 23, 2023 Jun 21, 2023
8-K Report | Data 8-K Jun 20, 2023 Jun 14, 2023
SC 13G Report SCHEDULE 13G May 30, 2023
8-K Report | Data 8-K May 9, 2023 May 9, 2023
10-Q Report | Data 10-Q May 9, 2023 Mar 31, 2023
8-K Report | Data 8-K May 9, 2023 May 9, 2023
8-K Report | Data 8-K Mar 31, 2023 Mar 27, 2023
10-K Report | Data 10-K Mar 10, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 10, 2023 Mar 10, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G/A Report JHG PLC OWNS <5% Feb 9, 2023
SC 13G/A Report Feb 9, 2023
SC 13G Report Jan 23, 2023
10-Q Report | Data 10-Q Nov 10, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 10, 2022 Nov 10, 2022
8-K Report | Data 8-K Sep 22, 2022 Sep 21, 2022
10-Q Report | Data 10-Q Aug 9, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 9, 2022 Aug 9, 2022
8-K Report | Data 8-K Jun 15, 2022 Jun 14, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K May 10, 2022 May 10, 2022
8-K Report | Data 8-K May 2, 2022 May 2, 2022
10-K Report | Data 10-K Mar 18, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 18, 2022 Mar 18, 2022
SC 13G Report JANUS HENDERSON GROUP PLC OWNS 5.8% OF JANUX THERAPEUTICS Feb 14, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G Report Jan 10, 2022
SC 13D/A Report AMENDMENT NO. 1 Dec 17, 2021
10-Q Report | Data 10-Q Nov 9, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 9, 2021 Nov 9, 2021
8-K Report | Data 8-K Oct 1, 2021 Oct 1, 2021
8-K Report | Data 8-K Sep 9, 2021 Sep 7, 2021
8-K Report | Data 8-K Aug 27, 2021 Aug 25, 2021
10-Q Report | Data 10-Q Aug 10, 2021 Jun 30, 2021
8-K Report | Data 8-K Aug 10, 2021 Aug 10, 2021
8-K Report 8-K Jul 16, 2021 Jul 15, 2021
SC 13G Report SC 13G Jun 25, 2021
SC 13D Report SC 13D Jun 25, 2021
SC 13D Report SCHEDULE 13D Jun 22, 2021
SC 13D Report SC 13D Jun 16, 2021
8-K Report 8-K Jun 15, 2021 Jun 15, 2021